News & Updates
Filter by Specialty:
HCV reinfection highest among people with ongoing injecting drug use
Reinfection with hepatitis C virus (HCV) is low among people receiving opioid agonist therapy (OAT) but appears to be at its peak during the first 24 weeks following treatment completion and among those with ongoing injecting drug use and needle‒syringe sharing, a study has found.
HCV reinfection highest among people with ongoing injecting drug use
14 Aug 2022Depression, anxiety, sleep troubles common in primary Sjögren’s syndrome
Patients with primary Sjögren’s syndrome (pSS) show high levels of depression, anxiety, and sleep disturbances, reports a recent study. Cognitive impairments are also prevalent in this patient population.
Depression, anxiety, sleep troubles common in primary Sjögren’s syndrome
13 Aug 2022Aquatic physical therapy boosts outcomes in women with breast cancer
Women with breast cancer may benefit significantly from aquatic physical therapy, which reduces fatigue while also improving quality of life (QoL), reports a recent meta-analysis.
Aquatic physical therapy boosts outcomes in women with breast cancer
13 Aug 2022Silent brain infarcts, peripheral vascular disease predict CV events in hypertensive patients
Silent brain infarcts (SBI) and ankle-to-brachial index (ABI) <0.9 are independently associated with a higher risk of cardiovascular (CV) events in hypertensive individuals, suggests a study.